News
On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...
A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain ...
This potential loss of strength when taking Ozempic could be a particular concern for adults over the age of 60 who are at a higher risk of muscle loss and reduced mobility.
Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...
Lizzo opened up about her dramatic weight loss in a recent interview, and the singer says that even though she’s dropped down ...
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...
Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--had been in short supply as the company raced to increase production and meet surging demand. But the drug came off ...
President Donald Trump provided new details about his plan to impose tariffs on foreign-made pharmaceuticals, but the White ...
A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...
Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...
Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results